Albany IR

CRF Index Page

   

  • CRF 1: Visit 1 - Inclusion and Exclusion Criteria
  • CRF 2: Visit 1 - Informed Consent and Demographics
  • CRF 3: Visit 1 - Baseline History
  • CRF 4: Visit 1 - Baseline Physical Examination
  • CRF 5: Visit 1 - Baseline UFS-QOL
  • CRF 5: Visit 1 - Baseline UFS-QOL Scoring
  • CRF 6: Visit 1 - Baseline Concomitant Medications
  • CRF 7: Visit 1 - Baseline Laboratory Evaluation
  • CRF 8: Visit 2 - Pre-Procedure MRI (FOR CORE LAB)
  • CRF 9: Visit 3 - Randomization
  • CRF 10: Visit 3 - Embolization Procedure
  • CRF 11: Visit 3 - Peri-Procedural Concomitant Medications
  • CRF 12: Visit 3 - Peri-Procedural Adverse Events
  • CRF 13: Visit 3 - Post-Embolization Recovery
  • CRF 14: Visit 4 - 1 Month Post-Procedure Visit
  • CRF 15: Visit 4 - 1 Month Concomitant Medications
  • CRF 16: Visit 4 - 1 Month Adverse Events
  • CRF 17: Visit 5 - 3 Month UFS-QOL
  • CRF 17: Visit 5 - 3 Month UFS-QOL Scoring
  • CRF 18: Visit 5 - 3 Month Concomitant Medications
  • CRF 19: Visit 5 - 3 Month Adverse Events
  • CRF 20: Visit 5 - 3 Month Post-Procedure MRI (FOR CORE LAB)
  • CRF 21: Visit 6 - 6 Month UFS-QOL
  • CRF 21: Visit 6 - 6 Month UFS-QOL Scoring
  • CRF 22: Visit 6 - 6 Month Concomitant Medications
  • CRF 23: Visit 6 - 6 Month Adverse Events
  • CRF 24: Visit 7 - 12 Month UFS-QOL
  • CRF 24: Visit 7 - 12 Month UFS-QOL Scoring
  • CRF 25: Visit 7 - 12 Month Concomitant Medications
  • CRF 26: Visit 7 - 12 Month Adverse Events